Advertisement

U.S. markets open in 4 hours 27 minutes

S&P Futures
4,235.00
+25.25(+0.60%)
Dow Futures
33,479.00
+175.00(+0.53%)
Nasdaq Futures
13,400.50
+89.25(+0.67%)
Russell 2000 Futures
1,990.80
+14.50(+0.73%)
Crude Oil
94.06
-0.28(-0.30%)
Gold
1,802.30
-4.90(-0.27%)

Advertisement

Clinuvel Pharmaceuticals Limited (CUV.AX)

ASX - ASX Delayed Price. Currency in AUD

Add to watchlist

19.64

-0.73

(-3.58%)

At close: 04:10PM AEST

Advertisement

Full screen

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	20.37
Open	20.20
Bid	19.63 x 84100
Ask	19.65 x 12400
Day's Range	19.53 - 20.20
52 Week Range	13.16 - 44.67
Volume	60,731
Avg. Volume	142,429

Market Cap	970.418M
Beta (5Y Monthly)	0.88
PE Ratio (TTM)	41.79
EPS (TTM)	0.47
Earnings Date	Aug 21, 2022 - Aug 26, 2022
Forward Dividend & Yield	0.03 (0.12%)
Ex-Dividend Date	Sep 02, 2021
1y Target Est	26.31

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

N/A

Subscribe to Yahoo Finance Plus to view Fair Value for CUV.AX

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

All

News

Press Releases

Simply Wall St.
Estimating The Fair Value Of Clinuvel Pharmaceuticals Limited (ASX:CUV)
Does the August share price for Clinuvel Pharmaceuticals Limited ( ASX:CUV ) reflect what it's really worth? Today, we...
- A Look At The Intrinsic Value Of Vivint Smart Home, Inc. (NYSE:VVNT)
  Simply Wall St.
- Estimating The Fair Value Of Kimball Electronics, Inc. (NASDAQ:KE)
  Simply Wall St.
Simply Wall St.
Do Insiders Own Lots Of Shares In Clinuvel Pharmaceuticals Limited (ASX:CUV)?
The big shareholder groups in Clinuvel Pharmaceuticals Limited ( ASX:CUV ) have power over the company. Insiders often...
GlobeNewswire
CLINUVEL progresses vitiligo treatment program
Novel approach to addressing pigment loss disorder affecting an estimated 45 million individuals worldwide Vitiligo repigmentation in CLINUVEL's CUV102 study Initial clinical studies of afamelanotide showed the drug could repigment skin. This patient received four afamelanotide implants and NB-UVB light therapy over six months, largely repigmenting lesions on their eyelids. Images taken at days 0 and 171 of CUV102 study, courtesy of the study investigator. MELBOURNE, Australia, May 09, 2022 (GLO